Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
Cardiovascular management in patients with Fabry disease

Cardiovascular management in patients with Fabry disease

Management in Patients with Fabry Disease.

Cardiovascular management in patients with Fabry disease

Cardiovascular management in patients with Fabry disease

Management in Patients with Fabry Disease.

Cardiovascular management in patients with Fabry disease

Cardiovascular management in patients with Fabry disease

Management in Patients with Fabry Disease.

Cardiovascular management in patients with Fabry disease

Cardiovascular management in patients with Fabry disease

Management in Patients with Fabry Disease.

Cardiovascular management in patients with Fabry disease

Cardiovascular management in patients with Fabry disease

Management in Patients with Fabry Disease.

Kurzvortrag Beyfortus (Nirsevimab)

Kurzvortrag Beyfortus (Nirsevimab)

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

Summary of The UK Prospective Diabetes Study (UKPDS).

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Summary of Aschner P, et al. Diabetologia. 2020;63(4):711-721.

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

Summary of The UK Prospective Diabetes Study (UKPDS).

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Summary of Aschner P, et al. Diabetologia. 2020;63(4):711-721.

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

How Does Glycaemic Control Impact Complications in Type 2 Diabetes?

Summary of The UK Prospective Diabetes Study (UKPDS).

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Why is Glycaemic Control in Type 2 Diabetes Still a Challenge?

Summary of Aschner P, et al. Diabetologia. 2020;63(4):711-721.